<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/290ee–3" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/290ee–3/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/290ee–3/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_290ee_3"><akn:num>290ee–3</akn:num><akn:heading>State demonstration grants for comprehensive opioid abuse response</akn:heading><akn:content><akn:p>§ 290ee–3. State demonstration grants for comprehensive opioid abuse response(a) DefinitionsIn this section:(1) DispenserThe term “dispenser” has the meaning given the term in section 802 of title 21.


(2) PrescriberThe term “prescriber” means a dispenser who prescribes a controlled substance, or the agent of such a dispenser.


(3) Prescriber of a schedule II, III, or IV controlled substanceThe term “prescriber of a schedule II, III, or IV controlled substance” does not include a prescriber of a schedule II, III, or IV controlled substance that dispenses the substance—(A) for use on the premises on which the substance is dispensed;

(B) in a hospital emergency room, when the substance is in short supply;

(C) for a certified opioid treatment program; or

(D) in other situations as the Secretary may reasonably determine.


(4) Schedule II, III, or IV controlled substanceThe term “schedule II, III, or IV controlled substance” means a controlled substance that is listed on schedule II, schedule III, or schedule IV of section 812(c) of title 21.



(b) Grants for comprehensive opioid abuse response(1) In generalThe Secretary shall award grants to States, and combinations of States, to implement an integrated opioid abuse response initiative.


(2) PurposesA State receiving a grant under this section shall establish a comprehensive response plan to opioid abuse, which may include—(A) education efforts around opioid use, treatment, and addiction recovery, including education of residents, medical students, and physicians and other prescribers of schedule II, III, or IV controlled substances on relevant prescribing guidelines, the prescription drug monitoring program of the State described in subparagraph (B), and overdose prevention methods;

(B) establishing, maintaining, or improving a comprehensive prescription drug monitoring program to track dispensing of schedule II, III, or IV controlled substances, which may—(i) provide for data sharing with other States; and

(</akn:p></akn:content><akn:subsection eId="subsec_290ee_3_a"><akn:num>(a)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(a) Definitions In this section:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_3_b"><akn:num>(b)</akn:num><akn:heading>Grants for comprehensive opioid abuse response</akn:heading><akn:content><akn:p>(b) Grants for comprehensive opioid abuse response</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_290ee_3_c"><akn:num>(c)</akn:num><akn:heading>Authorization of funding</akn:heading><akn:content><akn:p>(c) Authorization of funding For the purpose of carrying out this section, there are authorized to be appropriated $5,000,000 for each of fiscal years 2017 through 2021.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>